ATE313T1 - Antigenpraeparat verwendbar fuer vakzine oder als zwischenprodukt dafuer und verfahren zu seiner herstellung. - Google Patents

Antigenpraeparat verwendbar fuer vakzine oder als zwischenprodukt dafuer und verfahren zu seiner herstellung.

Info

Publication number
ATE313T1
ATE313T1 AT79101777T AT79101777T ATE313T1 AT E313 T1 ATE313 T1 AT E313T1 AT 79101777 T AT79101777 T AT 79101777T AT 79101777 T AT79101777 T AT 79101777T AT E313 T1 ATE313 T1 AT E313T1
Authority
AT
Austria
Prior art keywords
vaccine
thereor
manufacture
antigen preparation
preparation usable
Prior art date
Application number
AT79101777T
Other languages
German (de)
English (en)
Inventor
Alfred Mayer Prince
John Andrew Vnek
Original Assignee
New York Blood Center, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Blood Center, Inc. filed Critical New York Blood Center, Inc.
Application granted granted Critical
Publication of ATE313T1 publication Critical patent/ATE313T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10161—Methods of inactivation or attenuation
    • C12N2730/10162—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT79101777T 1978-06-07 1979-06-06 Antigenpraeparat verwendbar fuer vakzine oder als zwischenprodukt dafuer und verfahren zu seiner herstellung. ATE313T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91342278A 1978-06-07 1978-06-07
EP79101777A EP0005864B1 (en) 1978-06-07 1979-06-06 Antigenic composition useful as a vaccine or vaccine intermediate, and process for preparing same

Publications (1)

Publication Number Publication Date
ATE313T1 true ATE313T1 (de) 1981-11-15

Family

ID=25433258

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79101777T ATE313T1 (de) 1978-06-07 1979-06-06 Antigenpraeparat verwendbar fuer vakzine oder als zwischenprodukt dafuer und verfahren zu seiner herstellung.

Country Status (8)

Country Link
EP (1) EP0005864B1 (es)
JP (1) JPS54160716A (es)
AT (1) ATE313T1 (es)
AU (1) AU530195B2 (es)
CA (1) CA1117010A (es)
DE (1) DE2961060D1 (es)
MX (1) MX6290E (es)
ZA (1) ZA792485B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270955B1 (en) 1978-12-22 2001-08-07 Biogen, Inc. Pharmaceutical compositions and methods for producing antibodies to hepatitis b virus and kits and methods for detecting antibodies to hepatitis b virus
JPH0625069B2 (ja) * 1981-01-29 1994-04-06 ブリティッシュ・テクノロジー・グループ・リミテッド Ｂ型肝炎ワクチン製造方法
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
GB8321789D0 (en) * 1983-08-12 1983-09-14 Biogen Nv Vaccines and compositions against hepatitis
AU579148B2 (en) * 1984-03-09 1988-11-17 Scripps Clinic And Research Foundation Synthetic hepatitis b virus vaccine including both t cell and b cell determinants
JPS60197629A (ja) * 1984-03-16 1985-10-07 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
JPH06503231A (ja) * 1991-09-18 1994-04-14 アムジエン・インコーポレーテツド 胆汁酸塩を含有するｂ型肝炎ワクチン製剤
CN111511800B (zh) 2017-10-30 2023-11-28 武田药品工业株式会社 灭活脂包膜病毒的环境相容性去污剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1012445B (it) * 1973-05-21 1977-03-10 Siderurgie Fse Inst Rech Procedimento per la dissulfurazione dei metalli fusi
JPS5714653B2 (es) * 1974-06-21 1982-03-25
SE437329B (sv) * 1975-03-14 1985-02-25 Community Blood Council Sett att ur blodserum framstella vaccin mot virushepatit
US4017360A (en) * 1975-05-14 1977-04-12 Merck & Co., Inc. Method for purifying hepatitis B antigen
GB1518582A (en) * 1975-11-17 1978-07-19 Community Blood Council Viral hepatitis vaccine
JPS53104724A (en) * 1977-02-23 1978-09-12 Green Cross Corp:The Preparation of uniform hbsag particles

Also Published As

Publication number Publication date
CA1117010A (en) 1982-01-26
ZA792485B (en) 1980-06-25
MX6290E (es) 1985-03-18
AU530195B2 (en) 1983-07-07
EP0005864B1 (en) 1981-10-21
JPS54160716A (en) 1979-12-19
AU4767179A (en) 1979-12-13
EP0005864A1 (en) 1979-12-12
DE2961060D1 (en) 1981-12-24

Similar Documents

Publication Publication Date Title
DE69031556D1 (de) Antigene sowie Verfahren zu deren Herstellung
GB2070621B (en) Nucleotidic sequence coding the surface antigen of the hepatitis b virus vector containing said nucleotidic sequence process allowing the obtention thereof and antigen obtained thereby
AT370427B (de) Verfahren zur herstellung von submikroskopischen teilchen
ATE313T1 (de) Antigenpraeparat verwendbar fuer vakzine oder als zwischenprodukt dafuer und verfahren zu seiner herstellung.
IE780716L (en) Hepatitis b core antigens.
ATA980275A (de) Verfahren zur herstellung eines schuetzenden antigens von bordetella pertussis
BE838474A (fr) Detection de l'antigene de surface de l'hepatite b par agglutination de latex
SE7602871L (sv) Vaccin for aktiv immunisering
ATA75980A (de) Verfahren zur herstellung von in spruehgetrocknetenreinigungsmitteln verwendbaren zeolith-alkyl- benzolsulfonat-zusammensetzungen mit hohem feststoffgehalt
ATE175445T1 (de) Verfahren zur gewinnung von rekombinantem hepatitis b virus (hep b) oberflächeantigen
EP0339668A3 (en) Hepatitis a virus antigen
ATE4282T1 (de) Verfahren zur herstellung von toxoplasmenbereitungen fuer die toxoplasmosediagnose und die so hergestellten bereitungen.
AT358167B (de) Verfahren zur herstellung von fruehsommer- -meningoenzephalitis-virus (fsme-virus)- -vakzinen
GB2064322B (en) Process for purifying particles of biological origin particularly the surface antigen of the virus of hepatitis b (aghbs)
PT69953A (en) Process for preparing a composition comprising a lyophilized herpes virus
FR2464269B1 (fr) Sequence nucleotidique codant l'antigene de surface du virus de l'hepatite b, procede permettant son obtention et antigene obtenu
Černá et al. CONTRIBUTION TO THE SER O LOGICAL, DIA (; NO S IS OF SARCO CYSTO SIS
HUT46236A (en) Process for producing and utilizing antigenes of treponema hyodysenteriae
JPS5244229A (en) Method of making serological reagent for syphilis
IT7849082A0 (it) Antigene di superficie dell'epatite b
JPS5344620A (en) Recovering of immobilized vaccine and specific antigen
Evseeva et al. ELISA: Preparation and characteristics of Soviet reagents for detection of hepatitis B virus surface antigen in blood sera.
XU EVALUATION OF DIAGNOSTIC SIGNIFICANCE OF ANTI-HBc IgM IN SUBCLINICAL HEPATITIS B INFECTION
JPS5644850A (en) Serological early stage diagnosis of a-type acute hepatitis
ATA219889A (de) Komplex geeignet zur durchfuehrung eines verfahrens zur reinigung von pre-s-hepatitis-bvirus-oberfl|chenantigen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee